The potential role of testosterone in central serous chorioretinopathy
- 1Department of Ophthalmology, University Hospital, Basle, Switzerland
- 2Division of Endocrinology, Department of Internal Medicine, University Hospital, Basle, Switzerland
- 3Department of Ophthalmology, University Hospital, Basle, Switzerland
- Correspondence to: Dr M C Grieshaber Department of Ophthalmology, University Hospital Basle, Mittlere Strasse 91, PO Box, CH-4031 Basle, Switzerland; mgrieshaber{at}uhbs.ch
- Accepted 1 July 2006
Risk factors for central serous chorioretinopathy (CSCR) are male gender, psychological stress, type-A personality, corticoid–steroid treatment and pregnancy. The reason for the presence of male gender as a risk factor is not yet clear. One possibility is a direct influence of androgens. We report a case of a female patient who developed CSCR under testosterone treatment.
Case report
A 45-year-old non-pregnant woman presented with a 1-day history of metamorphopsia and scotoma in the right eye. She had no eye problems in the past, but her current profession as a manager exposed her to several stress situations. On examination of the right eye, the best-corrected visual acuity (BCVA) was 20/25; paracentral scotoma and metamorphopsia were confirmed …









